Drug class
Ophthalmic Decongestants
Ophthalmic decongestants are a class of topical sympathomimetic agents, primarily adrenergic receptor agonists such as tetrahydrozoline, naphazoline, phenylephrine, and low-dose brimonidine. Read more about Ophthalmic Decongestants
113 drugs in this class 39 manufacturers
Drugs in Ophthalmic Decongestants
VISINE-AC (tetrahydrozoline HCl/zinc sulfate)
EYE ALLERGY RELIEF (naphazoline HCl/pheniramine maleate)
REDNESS RELIEF (naphazoline HCl/glycerin)
REDNESS RELIEVER LUBRICANT (naphazoline HCl/polyethylene glycol 300)
REDNESS RELIEVER LUBRICANT (naphazoline HCl/polyethylene glycol 300)
ALLERGY EYE (NAPHAZOLINE-PHEN) (naphazoline HCl/pheniramine maleate)
EYE DROPS (WITH POVIDONE) (tetrahydrozoline HCl/dextran 70/polyethylene gl 400/povidone)
EYE DROPS (TETRAHYDROZOLINE) (tetrahydrozoline HCl)
Ophthalmic decongestants are a class of topical sympathomimetic agents, primarily adrenergic receptor agonists such as tetrahydrozoline, naphazoline, phenylephrine, and low-dose brimonidine.
They stimulate ocular alpha-adrenergic receptors, inducing local vasoconstriction of conjunctival and episcleral blood vessels.
This mechanism reduces vascular permeability and engorgement to temporarily relieve noninfectious conjunctival hyperemia.
The class is predominantly used for the symptomatic relief of eye redness and mild irritation secondary to allergic conjunctivitis, environmental exposures, or general ocular surface discomfort.
-
nih.gov
Ophthalmic decongestants are a class of topical sympathomimetic agents, primarily adrenergic receptor agonists such as tetrahydrozoline, naphazoline, phenylephrine, and low-dose brimonidine They stimulate ocular alpha-adrenergic receptors, inducing local vasoconstriction of conjunctival and episcleral blood vessels
-
reviewofophthalmology.com
Ophthalmic decongestants are a class of topical sympathomimetic agents, primarily adrenergic receptor agonists such as tetrahydrozoline, naphazoline, phenylephrine, and low-dose brimonidine They stimulate ocular alpha-adrenergic receptors, inducing local vasoconstriction of conjunctival and episcleral blood vessels
-
nih.gov
This mechanism reduces vascular permeability and engorgement to temporarily relieve noninfectious conjunctival hyperemia The class is predominantly used for the symptomatic relief of eye redness and mild irritation secondary to allergic conjunctivitis, environmental exposures, or general ocular surface discomfort
-
nih.gov
This mechanism reduces vascular permeability and engorgement to temporarily relieve noninfectious conjunctival hyperemia The class is predominantly used for the symptomatic relief of eye redness and mild irritation secondary to allergic conjunctivitis, environmental exposures, or general ocular surface discomfort
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.